By Adeyinka Joseph Alonge, a public health Specialist supporting Public health programs, HIV prevention, community services and surveillance programming , in Nigeria.
For more than two decades, the United States President’s Emergency Plan for AIDS Relief, commonly known as PEPFAR, has played a major role in Nigeria’s HIV response.
PEPFAR-supported programmes have helped expand HIV testing, antiretroviral treatment, laboratory systems, prevention services, health-worker capacity and community-based care. Nigeria has depended heavily on this support, particularly for maintaining treatment services for people living with HIV.
In 2026, however, the direction of HIV programming is changing.
The emphasis is gradually shifting from a mainly donor-supported response towards a more integrated and country-led system. Treatment continuity remains essential, but sustainability, domestic financing, community leadership, service integration and targeted prevention are receiving greater attention.
What Is the Current State of PEPFAR Support?
PEPFAR continues to support HIV treatment and prevention internationally. Data released by the United States Department of State in April 2026 showed that US-supported programmes were providing antiretroviral treatment to approximately 20.6 million people across more than 50 countries as of September 30, 2025.
Nigeria remains one of the countries where continued HIV assistance is particularly important. NACA previously estimated that PEPFAR support covered approximately 90% of the country’s HIV treatment burden, highlighting the scale of Nigeria’s historical dependence on external assistance.
The events of 2025 exposed the risks of this dependence. Interruptions associated with the review and suspension of some United States-funded activities affected sections of HIV prevention, community outreach and other services in Nigeria. UNAIDS reported that community-led and peer-led services connected to affected funding streams experienced disruptions.
This does not mean that HIV treatment has ended or that patients should stop attending clinics. It means that Nigeria is being pushed to strengthen local systems so that essential services are less vulnerable to changes in foreign assistance.
The Major Changes Shaping HIV Programs in 2026
1. Greater Nigerian Ownership
One of the clearest developments is the stronger focus on national ownership.
Nigeria launched a new National Strategic Plan for 2026 to 2030, describing the next phase of the country’s HIV response as sustainable, integrated and country-led.
This direction is likely to require greater participation from:
Federal and state governments
Primary healthcare systems
Nigerian implementing organisations
Community-based organisations
Private healthcare providers
Health insurance systems
Domestic manufacturers and supply-chain institutions
People living with HIV
The Nigerian government has already taken steps to protect treatment continuity. Following the 2025 funding disruption, the Federal Executive Council approved ₦4.8 billion for the procurement of 150,000 HIV treatment packs. The government also began considering stronger domestic financing mechanisms and greater private-sector participation.
The challenge will be turning emergency responses into predictable, long-term funding.
2. Protecting Treatment Continuity
Keeping people on effective antiretroviral therapy remains one of the most important priorities.
Effective antiretroviral treatment suppresses the amount of HIV in the blood, protects the immune system and reduces the risk of illness and transmission. When treatment does not control the virus as expected, healthcare workers must assess adherence, medicine interactions, drug resistance and other possible causes. A separate explainer discusses what HIV treatment failure means.
Interruptions in treatment can increase the risk of illness, drug resistance and onward HIV transmission. Programmes must therefore protect medicine supplies, viral-load testing, clinical monitoring, adherence support and systems for returning clients to care.
In a changing funding environment, the World Health Organization recommends prioritising essential services according to their contribution to health outcomes. This includes protecting services that prevent avoidable illness and death while adapting programmes in a phased and evidence-based manner.
For patients who are clinically stable, programmes may increasingly use differentiated service-delivery models. These can include longer medication refills, fewer routine clinic visits and access to medicines through suitable community arrangements.
WHO recommends differentiated approaches because patients do not all require the same intensity or frequency of care.
3. More Targeted HIV Testing
HIV testing programmes are moving away from simply testing the largest possible number of people.
The stronger approach is to identify individuals who may have had a meaningful exposure, offer confidential and voluntary testing, and ensure that anyone diagnosed with HIV is linked quickly to treatment.
Targeted approaches may include:
Provider-initiated testing based on clinical indications
Ethical index testing involving partners and biological children
HIV self-testing
Testing for pregnant women
Community testing in underserved areas
Services designed for adolescents and young adults
Testing linked to tuberculosis, sexually transmitted infection and other health services
WHO guidance supports differentiated HIV testing approaches and greater integration of testing with other health and prevention services.
The goal is not simply to report how many tests were conducted. The more meaningful measures are whether the right people were reached, whether newly diagnosed clients began treatment and whether those on treatment achieved viral suppression.
4. Prevention Is Becoming More Prominent
For years, much of the public discussion around HIV funding focused on treatment. In 2026, prevention is becoming increasingly prominent.
Nigeria’s National HIV Prevention Plan for 2026 to 2030 signals a shift towards a more proactive prevention response.
Important prevention priorities include:
Pre-exposure prophylaxis, or PrEP
Condom programming
HIV self-testing
Prevention of mother-to-child transmission
Services for adolescents and young people
Prevention services for key populations
Harm-reduction interventions
Stigma reduction
Gender-responsive programming
Community demand creation
Nigeria is also preparing for the wider introduction of long-acting HIV prevention options. One important development is lenacapavir, an injectable prevention medicine administered twice a year. Readers can learn more about how twice-yearly lenacapavir could expand HIV prevention choices, particularly for people who find daily PrEP tablets difficult to maintain.
Long-acting prevention could be particularly valuable for people facing adherence, access or stigma-related barriers. However, eligibility, national approval, procurement, provider training and reliable supply will determine its real-world impact.
PEPFAR previously announced plans to support the distribution of lenacapavir in selected high-burden countries beginning in 2026.
Long-acting prevention could be particularly valuable for people who find it difficult to take a daily PrEP tablet. Access, eligibility, cost, supply and implementation arrangements will still determine its real-world impact.
5. HIV Services Will Be More Integrated
HIV programmes have often operated through specialised structures. The current direction is towards integrating HIV services with the wider health system.
A person attending an HIV clinic may also require screening, prevention or treatment for tuberculosis, cervical cancer, hypertension, diabetes, mental health conditions, sexually transmitted infections, reproductive health needs and viral hepatitis. For background reading, see this overview of hepatitis B transmission, symptoms, treatment and prevention.
Integration can reduce repeated visits, support earlier diagnosis and make better use of limited health workers. However, it must be implemented carefully so that HIV services do not become slower, less confidential or more difficult to access.
A person attending an HIV clinic may also require screening or treatment for:
Tuberculosis
Hepatitis
Cervical cancer
Hypertension
Diabetes
Mental health conditions
Sexually transmitted infections
Reproductive health needs
WHO’s updated service-delivery guidance supports integrating HIV care with hypertension, diabetes and mental health services.
Integration can reduce repeated visits, improve early diagnosis and make better use of limited health workers. However, it must be implemented carefully so that HIV services do not become slower, less confidential or more difficult to access.
Community Linkage Models That Are Showing Results
One lesson from HIV programming is that diagnosing a person is not enough. The person must be linked to treatment, supported to remain in care and treated with dignity.
Community linkage models can help close the gap between receiving an HIV diagnosis and successfully starting or continuing treatment.
Peer Navigation
Peer navigators are people who understand the experiences and concerns of the population being served. They can explain available services, provide treatment education, help clients overcome fears and support referrals.
This approach can be particularly useful for adolescents, young people and populations that may experience stigma within conventional health settings.
Accompanied Referral
Giving someone the name or address of a health facility does not guarantee that the person will attend.
Accompanied referral provides more active support. A trained worker may help the client contact the facility, understand what to expect, arrange an appointment and, where appropriate, accompany the person through the referral process.
The aim is not to remove the client’s independence. It is to reduce practical and emotional barriers during a potentially stressful period.
Digital and Virtual Linkage
Phone calls, secure messaging, virtual outreach and appointment reminders can help connect people to services.
Digital methods are particularly useful for individuals who first seek information online or who are uncomfortable approaching a health facility without prior guidance.
However, digital programmes must protect confidentiality. Personal HIV information should not be exposed through shared phones, unsecured messages or poorly managed databases.
Community-Based Medication and Adherence Support
Stable clients may not need to return to a hospital every month solely to collect medicines.
Depending on national guidance and individual clinical needs, treatment programmes can use multi-month dispensing, community medication collection points and structured adherence groups.
WHO supports person-centred models involving less frequent clinic visits, longer medication dispensing and suitable community-based interventions.
Community-Led Monitoring
Community-led monitoring allows people receiving HIV services and community organisations to document barriers such as long waiting times, stigma, medicine shortages, unofficial charges and poor treatment by service providers.
The findings can then be used to improve the quality and accessibility of services.
PEPFAR has historically required operating units to support community-led monitoring, while UNAIDS describes community-led responses as a central part of achieving global HIV targets.
Community monitoring works best when it leads to action rather than simply producing another report.
Why Community Models Matter
Community linkage works because many barriers to HIV care exist outside the clinic.
A person may delay treatment because of:
Fear that others will learn their status
Transportation costs
Inconvenient clinic hours
Previous discrimination
Lack of accurate information
Concern about medicine side effects
Religious or cultural beliefs
Work or family responsibilities
Anxiety about lifelong treatment
Community workers can identify these barriers early and help clients find realistic solutions.
Nigeria’s previous national strategic plan established targets for increasing the proportion of HIV testing, treatment and prevention services delivered by community-led organisations. This reflects growing recognition that communities are not merely beneficiaries; they are also service-delivery partners.
What Do These Changes Mean for People Accessing HIV Care?
HIV Treatment Remains AvailablePeople diagnosed with HIV may have no symptoms, mild illness or signs of advanced disease. Clinical assessment remains important, but modern HIV care does not require a person to wait until symptoms develop before starting treatment. Readers looking for background information can review this explanation of HIV clinical stages in adults.
People receiving HIV treatment should continue taking their medication exactly as prescribed and attending appointments advised by their healthcare team.
They should not stop treatment because of rumours about donor funding.
Changes in contracts, programme structures or implementing partners do not automatically mean that antiretroviral medicines are unavailable.
Anyone experiencing difficulty collecting medication should contact the treatment facility or an authorised programme representative as early as possible.
Some Service Locations May Change
As programmes are reorganised or integrated into government systems, some patients may be transferred to another service point.
Patients should receive clear information about:
The new facility or collection location
Their next appointment
How to collect medication
Where viral-load and laboratory services will be provided
Whom to contact if there is a problem
Programmes should avoid abrupt transfers that increase the risk of treatment interruption.
Stable Patients May Have Fewer Clinic Visits
Multi-month dispensing can allow eligible patients to receive several months of medication at once.
This can reduce transport costs, waiting time and time away from work. It can also free healthcare workers to provide more intensive support to newly diagnosed patients and people with complex clinical needs.
Eligibility will depend on clinical stability, national guidance and the assessment of the healthcare team.
Prevention Options May Expand
People at substantial risk of acquiring HIV may have access to a wider range of prevention options, including oral PrEP, condoms, HIV self-testing and, as implementation develops, long-acting prevention.
No single prevention method is suitable for everyone. Individuals should receive accurate information and be supported to choose an appropriate option without coercion.
Prevention also depends on clear public understanding of the virus. Knowing what HIV is and how it affects the immune system can help people separate medical facts from myths, reduce stigma and make informed decisions about testing and prevention.
Patients May Receive More Services in One Place
Integration could allow patients to receive HIV care alongside services for tuberculosis, hypertension, diabetes, reproductive health or mental health.
This could make healthcare more convenient, but confidentiality and respectful treatment must remain central.
What Could Go Wrong?
The transition towards greater Nigerian ownership offers an important opportunity, but it also carries risks.
Possible problems include:
Insufficient domestic funding
Delayed release of approved funds
Medicine or laboratory supply interruptions
Loss of experienced health workers
Reduced community outreach
Weak referral systems
Poor coordination between government and implementing organisations
Declining attention to marginalised populations
Greater workload at public health facilities
Incomplete or fragmented patient records
The 2025 disruption demonstrated that community-led and prevention services can be particularly vulnerable when funding changes suddenly. UNAIDS reported that key-population-focused prevention services were affected across Nigeria and other countries.
Protecting treatment while allowing prevention and community services to weaken would be a serious mistake. Without effective prevention, testing and linkage, new infections may rise and people may be diagnosed later.
What Should Nigeria Prioritise?
Nigeria’s HIV response in 2026 should focus on five practical priorities.
First, the government should establish reliable domestic financing for medicines, laboratory services, prevention commodities and essential health workers.
Second, treatment continuity must be protected during every programme transition.
Third, community organisations should be included in planning, service delivery, monitoring and accountability.
Fourth, prevention programmes should focus on evidence, equity and populations with the greatest unmet need.
Fifth, HIV services should be integrated into the wider health system without sacrificing confidentiality, quality or accessibility.
The Bigger Picture
PEPFAR remains one of the most important global health initiatives ever established. The programme reports that it has saved an estimated 26 million lives since its creation.
But the long-term success of PEPFAR should not be measured only by the services it directly funds.
It should also be measured by whether countries can eventually maintain strong HIV programmes through their own institutions, professionals, communities and financing systems.
For Nigeria, 2026 represents a transition point.
The country must preserve the progress already made while building a response that is locally financed, properly integrated, community-informed and resilient enough to survive future political or funding changes.
For patients, the essential message remains simple: HIV is treatable, effective services remain important, and treatment should never be stopped without guidance from a qualified healthcare professional.
Frequently Asked Questions
Is PEPFAR leaving Nigeria in 2026?
There is no reliable public evidence that all PEPFAR-supported HIV services are ending in Nigeria. The programme is changing within a wider funding and sustainability transition. Some projects, contracts or delivery arrangements may change, but essential HIV treatment and prevention remain major public-health priorities.
Are antiretroviral medicines still free in Nigeria?
Antiretroviral medicines are generally provided through approved HIV treatment programmes without patients paying for the medicines themselves. Patients may still encounter costs connected to transportation, registration, laboratory services or other facility processes. These arrangements can differ by location.
Should patients stop taking HIV medicine during a funding change?
No. Patients should continue taking their medication as prescribed. Anyone unable to collect medicines should contact their treatment facility or an authorised programme representative immediately.
What is differentiated HIV service delivery?
Differentiated service delivery means organising HIV care according to the needs of different patients. A clinically stable patient may receive longer medication refills and require fewer clinic visits, while someone newly diagnosed or medically unwell may need closer follow-up.
What is community linkage in HIV care?
Community linkage refers to the support that helps a person move from HIV testing or outreach services into appropriate prevention, treatment or clinical care. It can involve peer navigation, accompanied referral, telephone follow-up, appointment support and community-based services.
No comments:
Post a Comment